Andrew Jordan Stevenson, MA, CAGS, LMHC, LCDP | |
600 Putnam Pike Ste 7, Greenville, RI 02828-1487 | |
(401) 949-2220 | |
Not Available |
Full Name | Andrew Jordan Stevenson |
---|---|
Gender | Male |
Speciality | Counselor - Mental Health |
Location | 600 Putnam Pike Ste 7, Greenville, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285057869 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | MHC00742 (Rhode Island) | Primary |
101YA0400X | Counselor - Addiction (substance Use Disorder) | CDP00598 (Rhode Island) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Andrew Jordan Stevenson, MA, CAGS, LMHC, LCDP 600 Putnam Pike Ste 7, Greenville, RI 02828-1487 Ph: (401) 949-2220 | Andrew Jordan Stevenson, MA, CAGS, LMHC, LCDP 600 Putnam Pike Ste 7, Greenville, RI 02828-1487 Ph: (401) 949-2220 |
News Archive
The link between environmental exposures and asthma has been clearly described, but a new study from researchers at the Harvard School of Public Health (HSPH) finds a strong association between domestic violence and asthma.
Premature infants born before 28-30 weeks of life are at high risk for many complications, among which the chances of dying from an infection starting in the intestine are very great. A new study published in the journal Nature Medicine reports that such infections are very much more likely if something interferes with the normal microbial accumulation in the gut. Adding certain bacterial strains protects against such infections, on the other hand.
Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on critical congenital heart disease screening for newborns using Masimo SET pulse oximetry.
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
› Verified 9 days ago
Melix Borelly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2 Vernon St, Greenville, RI 02828 Phone: 401-349-5882 | |
Katherine Frances Weekes, CCDP, LADC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 Putnam Pike Ste 7, Greenville, RI 02828 Phone: 401-949-2220 Fax: 401-633-6564 | |
Peter Grayson, LCDP Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 Putnam Pike, Suite 7, Greenville, RI 02828 Phone: 401-949-2220 | |
Audrey Rose Wayman, LCMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7 Austin Ave, Greenville, RI 02828 Phone: 401-349-3131 | |
Christopher James Cooke, Counselor Medicare: Not Enrolled in Medicare Practice Location: 13 Breezy Knoll Rd, Greenville, RI 02828 Phone: 401-413-2630 | |
Ms. Joann Elizabeth Esposito, LCDCS, ACDP II Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 Putnam Pike, Suite 7, Greenville, RI 02828 Phone: 401-949-2220 |